Premium
Caplacizumab treatment for acquired refractory thrombotic thrombocytopenic purpura
Author(s) -
Khan Sundas,
Landry Kara,
Umyarova Elvira
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16977
Subject(s) - adamts13 , thrombotic thrombocytopenic purpura , medicine , rituximab , von willebrand factor , gastroenterology , refractory (planetary science) , microangiopathic hemolytic anemia , platelet , plasmapheresis , context (archaeology) , surgery , immunology , antibody , astrobiology , biology , paleontology , physics , lymphoma
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom